The aim of this study was to investigate effects and mechanisms of electroacupuncture (EA) on blood glucose and insulin sensitivity in mice fed a high-fat diet. Both wild-type (WT) and adipose ectonucleotide pyrophosphate phosphodiesterase (ENPP1) transgenic (TG) mice were fed a high-fat diet for 12 wk; for each mouse, an intraperitoneal glucose tolerance test (IPGTT) and insulin tolerance test (ITT) were performed with or without EA at abdomen or auricular areas. A high-fat diet-induced insulin resistance in both WT and TG mice. In the WT mice, EA at 3 Hz and 15 Hz, but not at 1 Hz or 100 Hz, via CV4ϩCV12 significantly reduced postprandial glucose levels; EA at 3 Hz was most potent. The glucose level was reduced by 61.7% at 60 min and 74.5% at 120 min with EA at 3 Hz (all P Ͻ 0.001 vs. control). Similar hypoglycemic effect was noted in the TG mice. On the contrary, EA at auricular points increased postprandial glucose level (P Ͻ 0.03). 4). EA at 3 Hz via CV4ϩCV12 significantly enhanced the decrease of blood glucose after insulin injection, suggesting improvement of insulin sensitivity. Plasma free fatty acid was significantly suppressed by 42.5% at 15 min and 50.8% at 30 min with EA (P Ͻ 0.01) in both WT and TG mice. EA improves glucose tolerance in both WT and TG mice fed a high-fat diet, and the effect is associated with stimulation parameters and acupoints and is probably attributed to the reduction of free fatty acid. electroacupuncture; insulin resistance; glucose; vagal activity; free fatty acid DIABETES AFFECTS ABOUT 8.3% of Americans with an estimated total cost of over $174 billion (3). In addition, about 79 million American adults have prediabetes (3) and about 34% of American adults have metabolic syndrome (14). Insulin resistance is one of the major contributing factors for diabetes, prediabetes, and metabolic syndrome. Obesity is virtually always associated with insulin resistance (16). Insulin resistance increases with weight gain and decreases with weight loss (44), indicating that fat accumulation is not only associated with but, in fact, causes insulin resistance (5). In addition, insulin resistance is known to be attributed to elevated plasma free fatty acid (FFA) (6). Elevated plasma FFA and intracellular lipid inhibit insulin signaling, leading to a reduction in insulin-stimulated muscle glucose transport (13,27). The resulting suppression of muscle glucose transport leads to reduced muscle glycogen synthesis and glycosis.Obese patients with insulin resistance have been reported to have increased adipose tissue ectonucleotide pyrophosphate phosphodiesterase (ENPP1) (17). ENPP1 modulates insulin action by physical interaction with the ␣-subunit of the insulin receptor and inhibition of -subunit activation (20,24,36). In the transgenic model, previous studies elucidated that ENPP1 overexpression in insulin-sensitive tissues (liver, muscle, and brain) plays a role in insulin resistance and hyperglycemia, suggesting an important animal model to investigate insulin resistance. Recently, one stud...